Katleen De Preter

VIB-UGent Center for Medical Biotechnology — Belgium

Medicine · Health Sciences

49h-index28.4kcitations491works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(323), Cancer, Hypoxia, and Metabolism(80), Protein Degradation and Inhibitors(69), Cancer Genomics and Diagnostics(36), Ubiquitin and proteasome pathways(32)

Publications489 total

A benchmark of DNA methylation deconvolution methods for tumoral fraction estimation using DecoNFlow
2025Open Access
Defining the optimal setting for transcriptomic analyses on blood samples for response prediction in immunotherapy-treated NSCLC patients
Scientific Reports·2024Open Access
Blood collection tube and RNA purification method recommendations for extracellular RNA transcriptome profiling: A large-scale pre-analytical variable performance evaluation
2024· 1 citedOpen Access
Dramatic impact of blood collection tube and RNA purification method on extracellular RNA transcriptomes
2024Open Access
Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid
Clinical Epigenetics·2024· 18 citedOpen Access
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma
Molecular Therapy·2024· 1 citedOpen Access
Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid
Research Square (Research Square)·2024Open Access
Computational deconvolution of DNA methylation data from mixed DNA samples
Briefings in Bioinformatics·2024· 13 citedOpen Access
Evaluation of single-sample network inference methods for precision oncology
npj Systems Biology and Applications·2024· 8 citedOpen Access
Somatic Genomic Alterations in Neuroblastoma
Pediatric oncology·2024
MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression
Oncogene·2023· 8 citedOpen Access
Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma
International Journal of Molecular Sciences·2023Open Access
Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma
iScience·2023· 7 citedOpen Access
Case series on clinical applications of liquid biopsy in pediatric solid tumors: towards improved diagnostics and disease monitoring
Frontiers in Oncology·2023· 18 citedOpen Access
Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer
Journal for ImmunoTherapy of Cancer·2023· 33 citedOpen Access
Evaluation of single-sample network inference methods for precision oncology
2023Open Access
Supplementary Data from Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma
2023Open Access
Table S1 from Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma
2023Open Access
Table S2 from Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma
2023Open Access
Table S2 from Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma
2023Open Access
page 1 of 25Next →

Frequent Co-authors

Frank Speleman(31), Jo Vandesompele(27), Johannes H. Schulte(19), Alexander Schramm(16), Geneviève Laureys(16), Angelika Eggert(15), Nadine Van Roy(13), Pieter Mestdagh(12), Joëlle Vermeulen(10), Frank Westermann(9), Rogier Versteeg(9), Gudrun Schleiermacher(9), Matthias Fischer(8), Candy Kumps(8), Rosa Noguera(8), Björn Menten(7), Filip Pattyn(6), Anne De Paepe(6), Lukas C. Heukamp(6), Olivier Delattre(6)